LEGACY
ActiveSummary
LEGACY has been active since 2015 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €17,805 and a net result of €17,701. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 21% of 3,384 sector peers (NACE 62, financial year 2025). The computed 12-month bankruptcy probability is 0.9% (low).
History
Acts, filings and financial milestones
18-11
Gazette deed
Resignation: Alexander Schmitt (director)Appointment: BV "Travel Pharma" (director) · Permanent representative: Alexander Schmitt4 facts ▸
- General meeting, 31-01-2025
- Director resignation, Alexander Schmitt (director)
- Director appointment, BV "Travel Pharma" (director)
- Permanent representative, Alexander Schmitt
14-05
Gazette deed
Resignations: SCHMITT Alexander (manager) and BOULLART Marieke (manager)Appointments: SCHMITT Alexander (director) and BOULLART Marieke (director) · Amendment of the articles · Capital conversion13 facts ▸
- General meeting, 28-06-2024
- Amendment of the articles (2 times)
- Capital conversion, EUR, “van rechtswege omgezet” (deed in Dutch)
- Reserve release, “beschikbaar voor uitkering, opheffing statutair onbeschikbare eigen vermogensrekening” (deed in Dutch)
- Capital
- Director resignation, SCHMITT Alexander (manager)
- Director resignation, BOULLART Marieke (manager)
- Director appointment, SCHMITT Alexander (director (not named in the articles))
- Director appointment, BOULLART Marieke (director (not named in the articles))
- Other provision, “kwijting ontslagnemende zaakvoerder(s), volgende jaarvergadering” (deed in Dutch)
- Registered office clause, “Reytstraat 103,9700 Oudenaarde” (deed in Dutch)
- Power of attorney, Roel Mondelaers
- +1 further fact in this act
Show earlier events
About the unread acts
Of the 5 Belgian Official Gazette deeds we know for this company, 2 have been read. The other 3 have not been read yet: what they contain is neither established nor disproved here.